Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity
Coumar, M.S., Leou, J.S., Shukla, P., Wu, J.S., Dixit, A.K., Lin, W.H., Chang, C.Y., Lien, T.W., Tan, U.K., Chen, C.H., Hsu, J.T.A., Chao, Y.S., Wu, S.Y., Hsieh, H.P.(2009) J Med Chem 52: 1050-1062
- PubMed: 19140666 
- DOI: 10.1021/jm801270e
- Primary Citation of Related Structures:  
3FDN - PubMed Abstract: 
Aurora kinases have emerged as attractive targets for the design of anticancer drugs. Through structure-based virtual screening, novel pyrazole hit 8a was identified as Aurora kinase A inhibitor (IC(50) = 15.1 microM). X-ray cocrystal structure of 8a in complex with Aurora A protein revealed the C-4 position ethyl carboxylate side chain as a possible modification site for improving the potency ...